GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients

• Autores principales: Clemens Schotten (Autor), Bastian Ostertag (Autor), Jan-Peter Sowa (Autor), Paul Manka (Autor), Lars P. Bechmann (Autor), Gudrun Hilgard (Autor), Claudio Marquardt (Autor), Marc Wichert (Autor), Hidenori Toyoda (Autor), Christian M. Lange (Autor), Ali Canbay (Autor), Philip Johnson (Autor), Heiner Wedemeyer (Autor), Jan Best (Autor)
• Formato: Libro
• Publicado: MDPI AG, 2021-07-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Despite vaccination programs and direct antiviral treatments, the incidence of virus-related hepatocellular carcinoma (HCC) remains high, while ultrasound-based detection rates for early-stage HCC is continuously low. To address this insufficiency, we set out to characterize whether the GALAD score,...